SCHEDULE: Onconetix Stakeholder Discloses 6.1% Ownership

Keystone Capital Partners, RANZ Group, and Fredric Zaino have jointly filed a Schedule 13G, reporting beneficial ownership of 223,717 shares of Onconetix, Inc. common stock, representing 6.1% of the outstanding shares.

Summary

• Keystone Capital Partners, LLC, RANZ Group LLC, and Fredric Zaino have filed a Schedule 13G, indicating their beneficial ownership of 223,717 shares of Onconetix, Inc. common stock.
• This ownership stake represents 6.1% of the company's outstanding common stock as of June 5, 2026.
• The filing clarifies that RANZ Group manages Keystone, and Fredric Zaino controls RANZ Group, with shared voting and dispositive power attributed to all three entities.
• Certain potential share issuances are excluded from the reported beneficial ownership due to a 4.99% ownership prohibition, including shares from warrants, preferred stock conversion, and a common stock purchase agreement.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this filing as neutral. It provides transparency on ownership but lacks financial or operational details that would indicate a positive or negative outlook for the company.

Positives

• Disclosure of significant beneficial ownership by key entities, providing transparency to the market.
• The reporting parties are acting in concert, which can sometimes indicate a stable or strategic interest in the company.

Negatives

• The filing does not contain financial performance data or operational updates, limiting insight into the company's health.
• Potential future share issuances are subject to a 4.99% ownership cap, which could limit the reporting parties' ability to increase their stake without triggering restrictions.

Risks

• The filing does not explicitly detail risks associated with Onconetix, Inc. itself, as it is a Schedule 13G focused on ownership.
• Potential future share issuances are subject to a 4.99% ownership prohibition, which could lead to complex negotiations or limitations on the reporting parties' ability to exercise certain rights or convert securities.

Future Outlook

The filing does not contain forward-looking statements or guidance regarding the company's future performance. It solely focuses on reporting beneficial ownership.

Management Comments

• Each of RANZ Group and Mr. Zaino disclaim beneficial ownership of any of the securities covered by this statement, except to the extent of any pecuniary interest therein.

Industry Context

StockSavvy.ai notes that Schedule 13G filings are common for institutional investors and significant stakeholders to report their ownership stakes. This filing indicates a notable stake in Onconetix, Inc. by Keystone Capital Partners, RANZ Group, and Fredric Zaino, which could signal strategic interest or a passive investment.

Stakeholder Impact

• Shareholders gain clarity on the significant ownership held by Keystone Capital Partners, RANZ Group, and Fredric Zaino, which may influence market perception and trading activity.
• The 4.99% ownership cap on future issuances could impact the reporting parties' ability to increase their stake and potentially influence future corporate actions or control.

Next Steps

• The reporting persons will continue to file amendments to this Schedule 13G as required by SEC regulations.

Key Dates

Keywords

Onconetix, Schedule 13G, Beneficial Ownership, Keystone Capital Partners, RANZ Group, Fredric Zaino, Common Stock, SEC Filing